alendronate has been researched along with Cross Infection in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Alendronate treatment increases bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing bone resorption." | 3.85 | Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis. ( Chen, YC; Lin, WC, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC | 1 |
| Lin, WC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Orthopaedic Conservative Treatment in the Time of Covid-19 Pandemic[NCT04623346] | 262 participants (Anticipated) | Observational | 2020-03-11 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for alendronate and Cross Infection
| Article | Year |
|---|---|
Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis.
Topics: Aged; Alendronate; Bone Density Conservation Agents; Cross Infection; Female; Humans; Male; Osteopor | 2017 |